Oligo CVV Production
ID: 75D301-24-Q-78627Type: Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFCENTERS FOR DISEASE CONTROL AND PREVENTIONCDC OFFICE OF ACQUISITION SERVICESATLANTA, GA, 30333, USA

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

PSC

MEDICAL- LABORATORY TESTING (Q301)

Original Source

https://sam.gov/opp/356e8ea489264dc89d205ee060ef19e6/view
Timeline
    Description

    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking qualified contractors to provide rapid custom genetic products for the development of Candidate Vaccine Viruses (CVVs) against pandemic potential. The procurement includes single-stranded DNA oligonucleotides and double-stranded DNA gene fragments, with specific requirements for turnaround times, expected yields, and shipping arrangements to ensure timely delivery of these critical genetic materials. This initiative is vital for enhancing the nation's preparedness for future pandemics, emphasizing the need for flexibility in production to adapt to rapidly changing influenza strains. Interested vendors must submit their quotes by September 16, 2024, and can contact Timothy Joyce at xvf7@cdc.gov for further information.

    Point(s) of Contact
    Timothy Joyce
    xvf7@cdc.gov
    Files
    Title
    Posted
    A19. RFQ 75D301-24-Q-78627 Amended.doc
    The Centers for Disease Control and Prevention (CDC) issued a Request for Quotations (RFQ) for the procurement of rapid custom genetic products to develop Candidate Vaccine Viruses (CVVs) against pandemic potential. The RFQ outlines the requirement for single-stranded DNA oligonucleotides and double-stranded DNA gene fragments, detailing quantities, expected yields, turnaround times, and shipping arrangements. Suppliers must provide pricing for a maximum total quantity to be delivered over a one-year performance period, with monthly invoicing based on actual usage. The importance of these genetic products is underscored by the need for flexibility in production to address rapid changes in circulating influenza strains. Key documents within the RFQ include statements of work, evaluation factors, instructions to offerors, and contract clauses. The document emphasizes adherence to federal regulations, including accessibility standards and the importance of securing sensitive data. Vendor qualifications focus on proven capacity for timely delivery of genetic material, aligning with the CDC’s ongoing need to respond swiftly to public health threats. Overall, this RFQ underlines the CDC's commitment to enhancing the nation's preparedness for future pandemics through a streamlined procurement process for essential genetic resources.
    A19. RFQ 75D301-24-Q-78627 Final.doc
    The file details a Request for Quotations (RFQ) from the Centers for Disease Control and Prevention (CDC), specifically for rapid genetic material production to support the development of Candidate Vaccine Viruses (CVVs). The RFQ outlines the need for services including custom DNA oligonucleotides and double-stranded DNA gene fragments, emphasizing rapid turnaround times for samples ranging from 15 to over 2,200 base pairs in length. The work primarily aims to address the need for frequent production of genetic materials due to evolving influenza strains. The contract specifies quantities, pricing structures, and delivery timelines. Invoicing will occur monthly based on actual usage, with a performance period anticipated to last one year. Security protocols ensure no sensitive information leaves the government’s control, and vendors must meet qualifications related to production capacity and delivery speed. Compliance with Section 508 for accessibility is also mandated. This RFQ emphasizes the government's proactive approach to managing public health threats through vaccine development, fostering collaboration with capable contractors to enhance vaccine preparedness.
    Lifecycle
    Title
    Type
    Oligo CVV Production
    Currently viewing
    Solicitation
    Similar Opportunities
    CDC DFWED NARST Sensititre Supplies
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) is seeking to award a sole source contract for antimicrobial resistance testing supplies, specifically Sensititre™ broth microdilution testing products, from ThermoFisher Scientific. This procurement is essential for the National Antimicrobial Resistance Monitoring System (NARMS), which has utilized these proprietary materials since 1996 to ensure a standardized approach to monitoring enteric bacteria resistance. The unique nature of these supplies necessitates this sole source approach, as alternatives would require significant investments in new equipment and validation processes, potentially disrupting critical surveillance efforts. Interested parties may respond within 15 days to express their interest, with proposals directed to contract specialist Ashley Williams at dal3@cdc.gov.
    CIVICs Data Management and Coordinating Center (DMCC)
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to provide services for the renewal of the CIVICs Data Management and Coordinating Center (DMCC). The DMCC will support the CIVICs program by managing data, conducting analyses, and facilitating communication and coordination among various stakeholders, with a focus on advancing influenza vaccine research and development. This initiative is critical for enhancing the immunogenicity and durability of seasonal influenza vaccines and involves the operation of a scalable data management system, maintenance of public and private portals, and comprehensive program coordination. Interested parties must submit their tailored Capability Statements by 3:00 PM (Eastern Time) on January 23, 2025, to Maribel Miranda at maribel.miranda@nih.gov, with the anticipated contract award date around July 2026.
    Notice of Intent to Sole Source – Meso Scale Discovery (MSD) Lab Equipment Maintenance Service Contract
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), intends to issue a sole source contract for maintenance services of Meso Scale Discovery (MSD) lab equipment. The primary objective is to ensure the proper functioning and maintenance of specialized laboratory instruments used in HIV prevention research, which includes preventive maintenance and emergency repair services. This contract is critical for supporting the CDC's Division of HIV Prevention in conducting vital scientific studies related to HIV transmission and detection. Interested vendors must respond to the notice by January 19, 2025, and direct inquiries to Stephanie Reid at qsi5@cdc.gov, as the procurement will be conducted under the authority of FAR 13.106-1(b) and 10 U.S.C. 2304(c)(1).
    Pre-Solicitation FY 2025 CDC OS Emerging Public Health Priorities BAA
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is preparing to issue a Fiscal Year 2025 Broad Agency Announcement (BAA) for Applied Research aimed at addressing Emerging Public Health Priorities. This initiative seeks innovative research proposals in various areas, including infectious disease surveillance, wastewater surveillance, and substance use disorder recovery, to enhance public health strategies and responses to emerging threats. The BAA will be open for full and open competition, with a tentative issuance date of December 30, 2024, and a due date for concept papers set for January 30, 2025. Interested contractors must ensure they are registered in the System for Award Management (SAM) to be eligible for award, and further details will be available on SAM.gov.
    A--National Gene Vector Biorepository
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for the National Gene Vector Biorepository (NGVB) contract, aimed at supporting gene therapy research for the National Heart, Lung, and Blood Institute (NHLBI). The contract will involve archiving biological specimens, conducting DNA and RNA extractions, and developing assays, while ensuring compliance with FDA regulations and Good Laboratory Practices (GLP). This initiative is critical for advancing gene therapy capabilities and enhancing research resources, with an expected proposal submission deadline of January 10, 2025, and a revised due date for proposals set at 2:00 PM EST on January 15, 2025. Interested parties can contact Ethan J. Mueller at ethan.mueller@nih.gov or +1 301 496 2153 for further information.
    Long Read Sequencing Kits
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for the procurement of Long Read Sequencing Kits, specifically Oxford Nanopore brand or equivalent items, to support research on neurodegenerative diseases. The acquisition aims to supply the Center for Alzheimer’s Disease and Related Dementias with kits that will facilitate the identification of causative genes linked to Alzheimer's Disease and related disorders, utilizing long-read sequencing technology. This procurement is critical for advancing research in understanding and treating neurodegenerative diseases, with an anticipated delivery of the first order by September 30, 2025, and options for additional orders in subsequent years. Interested vendors must submit their quotations by 12:00 p.m. EST on January 24, 2025, to Andrea Clay at amcgee@nida.nih.gov, referencing Solicitation Number 75N95025Q00095.
    Decoding reagents, consumables, cell segmentation kits, sample prep and stand alone custom gene panel
    Agriculture, Department Of
    The Department of Agriculture, specifically the Agricultural Research Service, is seeking quotes for a range of decoding reagents, consumables, and custom gene panels necessary for conducting spatial transcriptomics research on avian influenza in chicken lungs. The procurement includes items such as Xenium Decoding Reagents, Advanced Panel Upgrades, and Cell Segmentation Kits, which are critical for analyzing the impact of the virus on various cell types and their transcriptomes. This acquisition is part of a broader effort to enhance understanding of viral effects on poultry health, with a firm fixed-price contract anticipated to be awarded based on the Lowest Price Technically Acceptable (LPTA) evaluation method. Interested vendors must submit their quotes electronically to Brian Brusky at brian.brusky@usda.gov by 5:00 PM Central Time on January 17, 2025, and ensure they are registered in the System for Award Management (SAM) prior to submission.
    Brand name or equal, Reagent needed for amplification of DNA for next generation sequencing in high-throughput assay for chromatin for The National Center for Advancing Translational Sciences (NCATS)
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) is seeking suppliers for a brand name or equal reagent necessary for the amplification of DNA for next-generation sequencing in high-throughput assays for chromatin, specifically for the National Center for Advancing Translational Sciences (NCATS). The procurement aims to acquire the NEBNext Ultra II Q5 Master Mix in a bulk order of 500 mL, which is critical for optimizing protocols and facilitating high-throughput screening. This reagent is essential for advancing medical research and enhancing the development of diagnostics and therapeutics across various human diseases. Interested vendors must submit their capability statements and relevant documentation by January 22, 2025, at 9 am Eastern Time to Giuliana Faller at giuliana.faller@nih.gov.
    Bulk Pharma Group B
    Health And Human Services, Department Of
    The Department of Health and Human Services (HHS) is seeking proposals for the procurement of a range of FDA-approved pharmaceuticals as part of the Bulk Pharma Group B initiative. The contract will require the delivery of specific injectable medications, including Acyclovir Sodium, Doxycycline, Levophed, Meropenem, Sodium Chloride, and sterile water, with quantities detailed in the attached Request for Proposal (RFP). This procurement is critical for maintaining the Strategic National Stockpile, ensuring a reliable supply of essential pharmaceuticals for disaster preparedness and response efforts. Interested vendors must submit their proposals by the specified deadline, and inquiries can be directed to primary contact Terri Reed at terri.reed@hhs.gov or secondary contact Kimberly Golden at kimberly.golden1@hhs.gov.
    Maintenance: MiSeq and NovaSeq 6000 Sequencers
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), is seeking to procure a one-year maintenance contract for its Illumina NovaSeq 6000 and MiSeq DNA sequencers. The contract will cover a Silver Support Plan, which includes full repair parts, labor, travel, and remote technical support, ensuring the continuous operation of these critical sequencing machines essential for high-throughput and accurate DNA analysis. Interested vendors must submit their quotations by January 27, 2025, at 12:00 PM EST, to Tina Robinson at robinsti@mail.nih.gov, and must be registered in the System for Award Management (SAM) to be eligible for award consideration.